Radiopharm Theranostics Limited's market cap is currently AU$72.30M. The company's EPS TTM is AU$-0.01; its P/E ratio is -1.46; Radiopharm Theranostics Limited is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is AUgt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in AUD
Radiopharm Theranostics Limited Earnings and Revenue History
